Compare GEHC & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | STZ |
|---|---|---|
| Founded | 1892 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Beverages (Production/Distribution) |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 24.6B |
| IPO Year | 2022 | 1994 |
| Metric | GEHC | STZ |
|---|---|---|
| Price | $65.52 | $146.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $88.38 | ★ $175.63 |
| AVG Volume (30 Days) | ★ 4.6M | 2.0M |
| Earning Date | 04-29-2026 | 04-08-2026 |
| Dividend Yield | 0.24% | ★ 2.74% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $20,625,000,000.00 | $9,139,000,000.00 |
| Revenue This Year | $7.12 | $0.73 |
| Revenue Next Year | $4.45 | $1.93 |
| P/E Ratio | $76.30 | ★ $24.93 |
| Revenue Growth | ★ 4.84 | N/A |
| 52 Week Low | $58.75 | $126.45 |
| 52 Week High | $89.77 | $178.14 |
| Indicator | GEHC | STZ |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 56.23 |
| Support Level | $60.08 | $136.02 |
| Resistance Level | $78.79 | $150.53 |
| Average True Range (ATR) | 1.83 | 3.83 |
| MACD | 0.31 | 0.79 |
| Stochastic Oscillator | 87.17 | 71.68 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.